Pioneer in phage-based diagnostics

Actiphage TB awarded US Patent grant for diagnostic kit

Actiphage TB enters third clinical trial.

“Significant association between positive Actiphage test and features of progressive TB infection.”

Actiphage – Confidence
to test for active TB

Phage-based diagnostics

PBD Biotech specialises in the use of novel bacteriophage-based diagnostics.

The company has developed proprietary, patented technology that can be used to detect the presence of mycobacteria – the cause of tuberculosis in humans and animals – in a blood sample.

Our mission

PBD Biotech aims to drive innovation in the novel use of phages, such as Actiphage, for TB screening and drug management.

PBD Biotech developers of Actiphage TB

PBD Biotech achieves ISO 13485 for medical devices

Latest

developers of phage-based diagnostics

Registered Company Address
B4 Parkside Knowledge Gateway
Nesfield Road
Colchester
CO4 3ZL
United Kingdom

info@pbdbio.com

Privacy and cookies policy

design: out of house